TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Sep 2022

Income Metrics

Revenue 10.6M
Gross Profit 15.6M 147.79%
Operating Income 9.1M 85.72%
Net Income 7.0M 66.63%
EPS (Diluted) €0.02

Balance Sheet Metrics

Total Assets 60.8M
Total Liabilities 53.9M
Shareholders Equity 6.9M
Debt to Equity 7.80

Cash Flow Metrics

Operating Cash Flow -7.2M
Free Cash Flow -2.2M

Revenue & Profitability Trend

Labiana Health S.A Income Statement From 2020 to 2023

Metric2023202220212020
Revenue i58.5M57.8M57.0M57.8M
Cost of Goods Sold i24.1M25.2M22.0M23.8M
Gross Profit i34.3M32.6M35.0M34.0M
Gross Margin % i58.7%56.4%61.4%58.8%
Operating Expenses
Research & Development i----
Selling, General & Administrative i-11.2M11.2M11.1M
Other Operating Expenses i12.0M11.7M11.7M11.7M
Total Operating Expenses i12.0M22.9M22.9M22.8M
Operating Income i-1.8M-2.4M653.9K2.5M
Operating Margin % i-3.2%-4.1%1.1%4.3%
Non-Operating Items
Interest Income i5.3K624.1K133.7K5.6K
Interest Expense i3.3M2.1M2.1M1.9M
Other Non-Operating Income----
Pre-tax Income i-5.3M-7.8M-2.1M541.2K
Income Tax i-776.0K1.3M-13.3K-532.5K
Effective Tax Rate % i0.0%0.0%0.0%-98.4%
Net Income i-4.5M-9.1M-2.1M1.1M
Net Margin % i-7.7%-15.7%-3.7%1.9%
Key Metrics
EBITDA i3.3M3.0M5.1M5.4M
EPS (Basic) i--€-0.25€0.15
EPS (Diluted) i--€-0.25€0.15
Basic Shares Outstanding i--72212557221255
Diluted Shares Outstanding i--72212557221255

Income Statement Trend

Labiana Health S.A Balance Sheet From 2019 to 2023

Metric20232022202120202019
Assets
Current Assets
Cash & Equivalents i3.0M2.5M3.3M1.5M41.2M
Short-term Investments i13.9K9.1K11.4K868.5K1.5M
Accounts Receivable i11.8M8.8M7.9M10.5M4.8M
Inventory i11.1M12.7M14.9M14.1M35.1M
Other Current Assets0---971.0K
Total Current Assets i29.0M28.8M29.4M29.3M117.6M
Non-Current Assets
Property, Plant & Equipment i1.3M1.2M1.1M1.1M12.0M
Goodwill i7.7M9.0M14.0M12.6M458.8M
Intangible Assets i7.7M9.0M11.5M11.4M81.3M
Long-term Investments-----
Other Non-Current Assets-00-1.0M
Total Non-Current Assets i30.1M32.0M39.0M36.7M344.7M
Total Assets i59.1M60.8M68.4M66.0M462.4M
Liabilities
Current Liabilities
Accounts Payable i8.8M11.3M8.6M9.0M20.1M
Short-term Debt i11.1M20.0M19.4M9.2M507.0K
Current Portion of Long-term Debt-----
Other Current Liabilities---0-
Total Current Liabilities i24.7M35.1M30.5M20.8M20.7M
Non-Current Liabilities
Long-term Debt i30.6M18.2M25.3M29.5M51.7M
Deferred Tax Liabilities i357.4K399.3K322.9K545.7K5.4M
Other Non-Current Liabilities00---
Total Non-Current Liabilities i31.0M18.8M26.4M30.9M51.7M
Total Liabilities i55.7M53.9M56.8M51.7M72.4M
Equity
Common Stock i722.1K722.1K618.8K618.8K371.7M
Retained Earnings i-4.4M-8.9M-1.8M1.1M-67.8M
Treasury Stock i200.1K294.7K0--
Other Equity-----
Total Shareholders Equity i3.4M6.9M11.5M14.3M348.6M
Key Metrics
Total Debt i41.7M38.2M44.8M38.6M52.2M
Working Capital i4.3M-6.3M-1.0M8.5M96.9M

Balance Sheet Composition

Labiana Health S.A Cash Flow Statement From 2020 to 2023

Metric2023202220212020
Operating Activities
Net Income i-5.3M-7.8M-2.1M541.2K
Depreciation & Amortization i----
Stock-Based Compensation i----
Working Capital Changes i387.5K44.2K2.3M-1.1M
Operating Cash Flow i-1.7M-5.7M2.2M1.4M
Investing Activities
Capital Expenditures i-1.6M-2.8M-2.3M-4.2M
Acquisitions i-02.4M-593.3K
Investment Purchases i-65.0K-932.7K-3.7M0
Investment Sales i556.4K3.4M0-
Investing Cash Flow i-1.2M-274.6K-4.8M-4.8M
Financing Activities
Share Repurchases i-158.6K-412.1K-1.1M0
Dividends Paid i----
Debt Issuance i19.5M736.7K1.8M4.6M
Debt Repayment i-16.3M-7.4M0-
Financing Cash Flow i4.3M-5.6M5.1M2.9M
Free Cash Flow i-4.7M-774.4K-858.7K-2.9M
Net Change in Cash i1.5M-11.6M2.5M-457.7K

Cash Flow Trend

Labiana Health S.A Key Financial Ratios

Valuation Ratios

Forward P/E 4.33
Price to Book 5.80
Price to Sales 0.41

Profitability Ratios

Profit Margin 0.38%
Operating Margin 3.32%
Return on Equity 6.92%
Return on Assets 5.72%

Financial Health

Current Ratio 1.30
Debt to Equity 1,378.08
Beta -0.44

Per Share Data

EPS (TTM) €-0.16
Book Value per Share €0.67

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lab27.9M-5.806.92%0.38%1,378.08
Laboratorios 2.7B20.564.8325.01%17.66%22.50
Almirall S.A 2.2B102.601.511.45%2.02%26.47
Faes Farma S.A 1.3B12.411.8014.83%19.37%11.48
Laboratorio Reig 240.1M42.141.103.03%1.89%31.04
Grifols, S.A 7.8B29.191.694.99%4.00%126.87

Financial data is updated regularly. All figures are in the company's reporting currency.